Align Technology, Inc. designs, manufactures, and markets a system of clear aligner therapy, intraoral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services. The company's Clear Aligner segment offers Invisalign Full, a treatment used for a range of malocclusion; Invisalign Teen treatment that addresses orthodontic needs of teenage patients, such as compliance indicators, compensation for tooth eruption, and six free single arch replacement aligners; and Invisalign Assist treatment for anterior alignment and aesthetically-oriented cases. It also provides Invisalign Express (10 and 5) and Invisalign Lite/i7 treatments for orthodontic cases, non-comprehensive treatment relapse cases, or straightening prior to restorative or cosmetic treatments; Invisalign Go, a solution for general practitioner dentists (GPs) to identify and treat patients with mild malocclusion; SmileDirectClub aligners for minor tooth movement; custom clear aligner retainers used to maintain tooth position and correct minor relapse; and SmartTrack, a custom-engineered material that delivers force for orthodontic tooth movements. The company's Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; and Restorative software for iTero, a software for GPs, prosthodontists, periodontists, and oral surgeons. It also provides Orthodontic software for iTero, a software for orthodontists for digital records storage, orthodontic diagnosis, Invisalign digital impression submission, and for the fabrication of printed models and retainers; CAD/CAM services, such as iTero Models and Dies, OrthoCAD iCast, and OrthoCAD iRecord; and Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner, as well as third party scanners and digital scans for Invisalign treatment submission. The company was founded in 1997 and is headquartered in San Jose, California.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ALGN
Previous Symbol
CUSIP01625510
Phone408-470-1000
Debt
Debt-to-Equity RatioN/A
Current Ratio1.98
Quick Ratio1.90
Price-To-Earnings
Trailing P/E Ratio54.01
Forward P/E Ratio43.14
P/E Growth1.96
Sales & Book Value
Annual Sales$1.47 billion
Price / Sales11.40
Cash Flow$4.1358 per share
Price / Cash50.80
Book Value$14.35 per share
Price / Book14.64
Profitability
EPS (Most Recent Fiscal Year)$3.89
Net Income$231.41 million
Net Margins16.89%
Return on Equity34.09%
Return on Assets21.59%
Miscellaneous
Employees8,715
Outstanding Shares79,980,000
Market Cap$18.03 billion
OptionableOptionable
Align Technology (NASDAQ:ALGN) Frequently Asked Questions
What is Align Technology's stock symbol?
Align Technology trades on the NASDAQ under the ticker symbol "ALGN."
How were Align Technology's earnings last quarter?
Align Technology, Inc. (NASDAQ:ALGN) announced its quarterly earnings results on Wednesday, October, 24th. The medical equipment provider reported $1.24 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.05. The medical equipment provider had revenue of $505.30 million for the quarter, compared to analysts' expectations of $503.14 million. Align Technology had a return on equity of 34.09% and a net margin of 16.89%. The business's revenue was up 31.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.01 earnings per share. View Align Technology's Earnings History.
When is Align Technology's next earnings date?
What guidance has Align Technology issued on next quarter's earnings?
Align Technology updated its fourth quarter earnings guidance on Wednesday, October, 24th. The company provided earnings per share guidance of $1.10-1.15 for the period, compared to the Thomson Reuters consensus estimate of $1.32. The company issued revenue guidance of $505-515 million, compared to the consensus revenue estimate of $544.91 million.Align Technology also updated its Q4 2018 guidance to $1.10-1.15 EPS.
What price target have analysts set for ALGN?
16 equities research analysts have issued twelve-month price objectives for Align Technology's shares. Their forecasts range from $230.00 to $430.00. On average, they anticipate Align Technology's stock price to reach $354.60 in the next year. This suggests a possible upside of 68.8% from the stock's current price. View Analyst Price Targets for Align Technology.
What is the consensus analysts' recommendation for Align Technology?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 3 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Align Technology.
Has Align Technology been receiving favorable news coverage?
Headlines about ALGN stock have been trending somewhat positive on Tuesday, InfoTrie Sentiment reports. The research firm ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Align Technology earned a news impact score of 1.9 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near term.
Are investors shorting Align Technology?
Align Technology saw a increase in short interest in October. As of October 31st, there was short interest totalling 2,255,506 shares, an increase of 53.2% from the October 15th total of 1,472,594 shares. Based on an average daily trading volume, of 2,315,206 shares, the days-to-cover ratio is currently 1.0 days. Currently, 3.1% of the shares of the company are sold short. View Align Technology's Current Options Chain.
Who are some of Align Technology's key competitors?
Some companies that are related to Align Technology include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), Steris (STE), WILLIAM DEMANT/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Inogen (INGN), Avanos Medical (AVNS), Establishment Labs (ESTA), Sientra (SIEN), RTI Surgical (RTIX) and Invacare (IVC).
Who are Align Technology's key executives?
Align Technology's management team includes the folowing people:
- Mr. Joseph M. Hogan, Pres, CEO & Director (Age 61)
- Mr. John F. Morici, CFO & Sr. VP of Global Fin. (Age 51)
- Mr. Raphael S. Pascaud, Chief Marketing Portfolio & Bus. Devel. Officer and Sr. VP of iTero Scanner & Services (Age 46)
- Mr. Stuart Hockridge, Sr. VP of Global HR (Age 46)
- Mr. Emory M. Wright, Sr. VP of Global Operations (Age 48)
Who are Align Technology's major shareholders?
Align Technology's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.58%), Renaissance Technologies LLC (3.47%), Polen Capital Management LLC (2.64%), FMR LLC (2.26%), Bank of New York Mellon Corp (1.36%) and Disciplined Growth Investors Inc. MN (1.17%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott and Warren S Thaler. View Institutional Ownership Trends for Align Technology.
Which major investors are selling Align Technology stock?
ALGN stock was sold by a variety of institutional investors in the last quarter, including Polen Capital Management LLC, First Republic Investment Management Inc., Korea Investment CORP, Renaissance Technologies LLC, Mitsubishi UFJ Trust & Banking Corp, Los Angeles Capital Management & Equity Research Inc., Victory Capital Management Inc. and Standard Life Aberdeen plc. Company insiders that have sold Align Technology company stock in the last year include C Raymond Larkin Jr, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Stuart A Hockridge, Thomas M Prescott and Warren S Thaler. View Insider Buying and Selling for Align Technology.
Which major investors are buying Align Technology stock?
ALGN stock was bought by a variety of institutional investors in the last quarter, including Winslow Capital Management LLC, BlackRock Inc., FMR LLC, TIAA CREF Investment Management LLC, TCW Group Inc., JPMorgan Chase & Co., Credit Suisse AG and Nomura Asset Management Co. Ltd.. View Insider Buying and Selling for Align Technology.
How do I buy shares of Align Technology?
Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Align Technology's stock price today?
One share of ALGN stock can currently be purchased for approximately $210.10.
How big of a company is Align Technology?
Align Technology has a market capitalization of $18.03 billion and generates $1.47 billion in revenue each year. The medical equipment provider earns $231.41 million in net income (profit) each year or $3.89 on an earnings per share basis. Align Technology employs 8,715 workers across the globe.
What is Align Technology's official website?
How can I contact Align Technology?
Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]
MarketBeat Community Rating for Align Technology (NASDAQ ALGN)
MarketBeat's community ratings are surveys of what our community members think about Align Technology and other stocks. Vote "Outperform" if you believe ALGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
